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Abstract 
Background: Exosomes are membrane nano‑vesicles secreted by a multitude of cells that harbor biological con‑
stituents such as proteins, lipids, mRNA and microRNA. Exosomes can potentially transfer their cargo to other cells, 
implicating them in many patho‑physiological processes. Mesenchymal stem cells (MSCs), residents of the bone 
marrow and metastatic niches, potentially interact with cancer cells and/or their derived exosomes. In this study, we 
investigated whether exosomes derived from adult T‑cell leukemia/lymphoma (ATL) cells act as intercellular messen‑
gers delivering leukemia‑related genes that modulate the properties of human MSCs in favor of leukemia. We hypoth‑
esized that the cargo of ATL‑derived exosomes is transferred to MSCs and alter their functional behavior to support 
the establishment of the appropriate microenvironment for leukemia.
Results: We showed that both ATL cells (C81 and HuT‑102) and patient‑derived cells released Tax‑containing 
exosomes. The cargo of HuT‑102‑derived exosomes consisted of miR‑21, miR‑155 and vascular endothelial growth 
factor. We demonstrated that HuT‑102‑derived exosomes not only deliver Tax to recipient MSCs, but also induce NF‑κB 
activation leading to a change in cellular morphology, increase in proliferation and the induction of gene expression 
of migration and angiogenic markers.
Conclusions: This study demonstrates that ATL‑derived exosomes deliver Tax and other leukemia‑related genes to 
MSCs and alter their properties to presumably create a more conducive milieu for leukemia. These findings highlight 
the contribution of leukemia‑derived exosomes in cellular transformation and their potential value as biomarkers and 
targets in therapeutic strategies.
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Background
Human T-cell lymphotropic virus type I (HTLV-I) is the 
causative agent of an aggressive CD4+ T cell neoplasm, 
adult T-cell leukemia/lymphoma (ATL) [1, 2]. Tax onco-
protein is responsible for the pathogenic potential of 
HTLV-I by activating the expression of viral and cellu-
lar genes involved in several pathways including nuclear 
factor-kappa B (NF-κB) [3–5]. NF-κB family mem-
bers consist of five closely associated subunits: RelA 
(p65), RelB, cRel, p50 and p52 that have transactivating 
or transrepressing functions. NF-κB activation by Tax 
involves the phosphorylation of IκB-α leading to its dis-
sociation from RelA/p50 dimer, its ubiquitination and 
subsequent proteasomal degradation. The heterodimer is 
translocated into the nucleus and activates the transcrip-
tion of target genes involved mainly in cell proliferation 
and survival [6–10].
Exosomes are nanoscale vesicles (30–100  nm) [11, 12] 
derived from the endosomes of multivesicular bodies that 
fuse with the plasma membrane leading to their release 
into the extracellular milieu. They contain common pro-
teins of the endosomal pathway and specific proteins 
that can be traced back to the cell of origin. Exosomes are 
released in vitro by multiple cell types including epithelial 
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cells, neuronal cells, adipocytes, immune cells, fibroblasts 
and cancer cells, implicating them in intercellular com-
munication. Exosomes are detected in vivo in most body 
fluids such as blood, urine, saliva, breast milk, amniotic 
fluid, ascites, synovial fluid, cerebrospinal fluid and semen, 
where they have the potential to be used as biomarkers 
[13–15]. The importance of exosomes is attributed to their 
roles in cell–cell communication through the delivery of 
signaling cues to target cells at distant sites, contributing 
to patho-physiological functions such as immune regula-
tion, programmed cell death, angiogenesis, inflammation, 
viral infection and cancer [15–18]. Whereas the role of 
exosomes derived from solid cancers has been extensively 
investigated in supporting tumor growth, angiogenesis, 
metastasis and drug resistance [17, 19], their function in 
hematological malignancies has not been fully assessed. 
Some studies highlighted their immuno-suppressive 
functions [20–23] whereas others reported an enhanced 
cytotoxic effect of immune cells pre-exposed to leukemia-
derived exosomes [20, 24–26]. In addition, many studies 
have focused on the interaction between leukemic cells and 
endothelial cells via exosomes. Taverna et al. demonstrated 
that exosomes from chronic myeloid leukemia (CML) cell 
lines trigger endothelial cell activation and angiogenesis 
due to IL-8-mediated increase in cell adhesion molecules 
[27, 28]. This angiogenic effect was attributed by other 
studies to specific exosomal microRNAs (miRNAs) that 
stimulate endothelial cell migration and tube formation 
[29, 30]. The importance of exosomal miRNAs is that they 
can freely shuttle between cells and alter cellular pathways 
involved in disease pathogenesis [31]. Distinct miRNA sig-
nature was attributed to many leukemia types including 
CML, acute myeloid leukemia (AML) and chronic lym-
phocytic leukemia (CLL) [32–34]. Recent data examined 
the role of leukemia-derived exosomes in delivering signal-
ing molecules that modulate the surrounding stromal cells 
to further support leukemia progression [34, 35]. Moreo-
ver, exosomes from HTLV-I positive cells were found to 
contain viral proteins and inflammatory mediators and to 
protect target cells from apoptosis [36].
The area of ATL modulation of the bone marrow niche, 
specifically MSCs, via exosomes has not been previ-
ously explored. In this study, we investigated whether 
exosomes derived from ATL cells can be transferred to 
MSCs, residents of the bone marrow and metastatic 
niches, and consequently alter their functional behavior 
in favor of leukemia. Our data showed that ATL-derived 
exosomes harbor Tax, along with other leukemia-related 
genes, and release their cargo into MSCs. The delivery 
of ATL-derived exosomes led to the activation of NF-κB 
pathway in recipient MSCs which resulted in the induc-
tion of Tax-dependent cell proliferation and expression of 
migration and angiogenesis genes.
Methods
Reagents
DMEM (low glucose), trypsin, phosphate buffered saline 
(PBS), heat-inactivated fetal bovine serum (FBS), bovine 
serum albumin (BSA), normal goat serum (NGS), for-
maldehyde 37  %, PKH26 Red Fluorescent Cell Linker 
Kit, Arsenic trioxide (As), anti-Actin and -GAPDH 
antibodies were purchased from Sigma Aldrich (USA). 
MSCs, RPMI 1640, penicillin/streptomycin (P/S) were 
from Lonza (USA). Recombinant human interferon-
alpha (IFN) or Roferon-A was obtained from Roche 
(Switzerland). Cell culture plastic ware was purchased 
from Corning (USA). Ultracentrifugation tubes and 
RevertAid 1st strand cDNA synthesis kit were from 
Thermo Scientific (USA). Nucleospin RNA II kit was 
from Macherey-Nagel (Germany). Primers were from 
TIB MOLBIOL (Germany). Western blot and quan-
titative PCR reagents were from BioRad Laboratories 
(USA). Luminol reagents and secondary antibodies, goat 
anti-mouse and goat anti-rabbit IgG-horseradish peroxi-
dase conjugated, were purchased from Santa Cruz Bio-
technology (USA). CD63 and TSG-101 antibodies were 
from Abcam (USA). Phospho-NF-κB p65 antibody was 
from Cell Signaling (USA). TaqMan® MicroRNA reverse 
transcription kit, primers, probes and 2× universal Mas-
ter Mix were purchased from Applied Biosystems (USA). 
VEGF enzyme-linked immunosorbent assay (ELISA) kit 
was from R&D systems (USA). Hoechst 33342, Prolong 
Anti-fade kit, CD9 antibody and Alexa 488 secondary 
antibody were from Life Technologies (USA). Confocal 
dishes were purchased from MatTek Corporation (USA). 
Scanning electron microscopy material was from Elec-
tron Microscopy Sciences (USA).
Cells and culture conditions
The leukemic cell lines used in this study are either 
HTLV-I negative (Molt-4) or positive (C81 and HuT-
102). Leukemic cell lines were maintained in RPMI 1640 
medium. MSCs were maintained in DMEM low glu-
cose medium. Media were supplemented with 10 % FBS 
and 1  % P/S. Patient-derived ATL cells (p-ATL) were 
obtained from frozen mononuclear cells of deceased ATL 
patients, as regulated by the American University Insti-
tutional Review Board. As previously described [37], 
peripheral blood from acute ATL patients was obtained 
and subjected to Ficoll gradient centrifugation. Mononu-
clear cells were collected and frozen. Primary ATL cells 
were thawed and used in culture experiments to collect 
exosomes. Cells were maintained in RPMI 1640 medium 
supplemented with 20  % FBS, 1  % P/S, 0.01  µg/ml of 
recombinant Interleukin-2 and 1 % phytohemagglutinin. 
All cell lines were maintained at 37  °C in a humidified 
incubator containing 5 % CO2.
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Isolation of leukemia‑derived exosomes
Exosomes were prepared from culture supernatants of 
leukemic cells by differential centrifugations. Briefly, leu-
kemic cell lines were maintained in their recommended 
media until they reach 70–80  % confluency. Then, 
media was replaced with serum-free media (to eliminate 
serum-derived exosomes) and the cells were returned 
to the incubator for 48–72  h. After collection, the cul-
ture supernatants were sequentially centrifuged at 300g 
for 10 min, 2000g for 20 min and 10,000g for 30 min at 
4 °C to pellet cells, dead cells and cell debris, respectively. 
The supernatants were then filtered using a 0.22 µm fil-
ter and centrifuged at 100,000g for 70 min at 4 °C to pel-
let the exosomes using the T865 rotor in a Sorvall WX 
Ultra Series Floor Model Centrifuge (Thermo Scientific, 
USA). The exosome pellet was washed in 1 ml PBS and 
centrifuged again at 100,000g for 70  min at 4  °C using 
S120-AT2 rotor in a Sorvall Discovery M120 Ultracen-
trifuge (Thermo Scientific, USA). The final exosome pel-
let was re-suspended in 50 µl PBS and stored at −80 °C. 
A further purification step was performed using sucrose 
cushion. In brief, the exosome pellet was re-suspended in 
25 ml PBS and was gently loaded on top of 4 ml of Tris/
Sucrose/Deuterium oxide solution in AH629 swinging 
rotor. Following centrifugation at 100,000g for 70  min 
at 4  °C, 3.5  ml of the sucrose cushion which now con-
tains the exosomes, were removed from the bottom of 
the tubes, diluted in 30  ml PBS and centrifuged again 
at 100,000g for 70  min at 4  °C. The exosome pellet was 
suspended in 50 µl PBS and stored at −80 °C for further 
experiments.
Scanning electron microscopic characterization 
of leukemia‑derived exosomes
The exosome pellet was fixed in 2  % paraformaldehyde 
and was left to adsorb on carbon adhesive tabs for 20 min 
in a dry environment. After one wash with PBS, the tabs 
were transferred to 1 % glutaraldehyde for 5 min and then 
washed several times in distilled water for 2 min each, for 
a total of eight washes. The fixed exosomes were dehy-
drated with an ascending gradient of ethanol (40, 60, 80 
and 97 %) for 5 min per incubation. After evaporation of 
ethanol, the tabs were left to dry at room temperature for 
24 h on a glass microscope slide. The tabs were removed 
with a clean forceps, mounted on aluminum specimen 
mounts and examined by Mira3 LM Scanning Electron 
Microscope (SEM) (Tescan, Czech Republic).
Co‑culture experiments
MSCs were seeded in 12 well or 6 well plates to assess 
proliferation or gene expression, respectively. Once cells 
reach 70–80  % confluency, 30  µg (for 12 well plates) 
or 60  µg (for 6 well plates) of purified exosomes were 
directly cultured with MSCs for 72  h. The amount of 
exosomes used to treat MSCs was comparable to other 
studies where it ranged between 5 µg [36, 38], 25 µg [39] 
and 75 µg [40] per 24 well plate. In cell proliferation stud-
ies, MSCs were either cultured alone or cultured with 
leukemic exosomes, with or without treatment with 
1 µM of As and 1000 units/ml of IFN.
Uptake and internalization of PKH26‑labeled exosomes
Exosomes were labeled with PKH26 according to the 
manufacturer’s protocol with modifications. Briefly, 
30 µg of HuT-102-derived exosomes were re-suspended 
in 1 ml of Diluent C. In another tube, 4 µl of PKH26 was 
mixed with 1 ml of Diluent C just prior to staining. The 
PKH26 suspension was mixed with the exosomes sus-
pension and incubated for 4  min, protected from light. 
The staining reaction was stopped by the addition of an 
equal volume of 1  % BSA and centrifuged at 100,000g 
for 70 min at 4 °C. The pellet was washed with PBS and 
centrifuged at 100,000g for 70 min at 4 °C. The exosome 
pellet was suspended in 200 µl of supplemented DMEM 
low glucose medium and cultured with a confluent layer 
of MSCs in a confocal dish. Following co-incubation for 
24 h, MSCs were washed with PBS, stained with Hoechst 
for 5 min, washed with PBS and fixed with 4 % formalde-
hyde. Images of exosome uptake by MSCs were acquired 
with LSM710 laser scanning microscope (Carl Zeiss, 
Germany).
Cell proliferation assays
The proliferation of MSCs following co-culture with 
exosomes (30  µg) was assessed by Trypan Blue Exclu-
sion assay. Cells were photographed and counted at day 3 
post-co-culture. Proliferation graphs were plotted as per-
centage of the control, cells cultured alone, adjusted to 
100 %. Each condition was counted in duplicate and three 
independent experiments were performed and plotted.
Transcriptional expression analysis
Total RNA was extracted from cells or from purified 
exosomes using Nucleospin RNA II extraction kit as per 
manufacturer’s instructions. Then, cDNA was synthe-
sized from 1 μg of total RNA using RevertAid 1st strand 
cDNA synthesis kit. Quantitative PCR (qPCR) was per-
formed using iQ SYBR Green Supermix in a CFX96 
system (BioRad Laboratories, USA). PCR parameters 
consisted of a pre-cycle of 95 °C for 3 min followed by 40 
cycles consisting of 95 °C for 10 s, x °C for 30 s, and 72 °C 
for 30 s (x being the annealing temperature for each set 
of primers listed in Table 1). A final extension at 72 °C for 
5 min was then performed followed by a melting curve, 
55 °C, with the temperature gradually increased (0.5 °C) 
to 95  °C. The fluorescence quantitative cycle (Cq) value 
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was obtained for each gene and normalized to that of the 
housekeeping gene, GAPDH. The comparative quantita-
tive cycle (ΔΔCq) method was used to describe the fold 
change in expression of the target gene in cells retrieved 
from co-cultures to the same cells cultured alone. Three 
independent experiments were performed and presented.
miRNA analysis
Following total RNA extraction, miRNA expression pro-
file was performed. A reverse transcription step was first 
performed on 10 ng of total RNA using a multiplex cDNA 
master mix containing 3 of the primers of interest (miR-
21, miR-155 and U6B). The PCR protocol applied was at 
16 °C for 30 min, then 42 °C for 30 min followed by 85 °C 
for 5 min, using I cycler PCR machine (BioRad Labora-
tories, USA). The cDNA samples were then subjected to 
a qPCR using specific TaqMan probes for miR-21, miR-
155 and U6B. The qPCR protocol comprised the follow-
ing steps: 95 °C for 10 min followed by 40 cycles of 95 °C 
for 15 s and finally 60 °C for 60 s. qPCR was performed 
in a CFX96 system (BioRad Laboratories, USA). The Cq 
value was obtained for each miRNA and normalized to 
that of the internal control, U6B. The ΔΔCq method was 
used to describe the fold change in expression of the tar-
get miRNA in the exosomes relative to their derived cell 
lines. Three independent experiments were performed 
and presented.
Protein expression analysis
Cells and their purified exosomes were solubilized in 
lysis buffer consisting of 0.125 M Tris–HCl (pH 6.8), 2 % 
sodium dodecyl sulfate and 10 % glycerol. After quantifi-
cation using BioRad DC protein assay kit, protein lysates 
(15  µg of exosomes and 100  µg of cells) were separated 
on 10 % SDS-PAGE gel under reducing conditions (Non-
reducing conditions for CD9 and CD63 antibodies). 
Proteins were transferred onto polyvinylidene difluoride 
membranes which were blocked in 5 % skimmed milk in 
0.05  % Tween-PBS. The blots were incubated with spe-
cific primary and secondary antibodies. Protein bands 
were detected by chemiluminescence using ChemiDoc 
MP Imaging System (BioRad Laboratories, USA). For 
quantification of the results, the blots were taken at dif-
ferent exposures, within linear detection range, and pro-
tein band densities were analyzed by Image J software 
after normalization to the housekeeping gene.
Immunofluorescence staining
MSCs were cultured, alone or with HuT-102 exosomes 
in confocal dishes for 72 h, fixed with ice-cold methanol 
and stored at −20  °C. Cells were then washed 3 times 
with PBS and blocked with 5 % NGS in PBS for 1 h in a 
humidified chamber. Cells were incubated with primary 
antibody for phospho-NF-κB p65 overnight at 4  °C, fol-
lowed by washing and incubation with IgG-conjugated 
AlexaFluor488 secondary antibody (1 µg/ml) for 1 h. The 
cells were then stained with Hoechst (1 µg/ml), mounted 
on microscopic slides using Prolong Anti-Fade and 
observed by LSM710 laser scanning microscope.
Enzyme‑linked immunosorbent assay
The levels of soluble VEGF were measured in HuT-102 
cell-free supernatant harvested after 72  h of culture or 
in their derived exosomes. VEGF levels were measured 
by enzyme-linked immunosorbent assay (ELISA) kit, as 
recommended by the manufacturer’s instructions. VEGF 
levels were calculated from duplicate measurements and 
were expressed as concentration after normalization to 
the total amount of protein in each sample.
Statistical analysis
Statistical significance between different conditions was 
determined using Student’s t test.
Results
Exosomes derived from ATL cells harbor Tax, miR‑21, 
miR‑155 and VEGF
The presence of secreted exosomes in the culture super-
natants of HTLV-I negative and positive cell lines was 
assessed by SEM and by the expression of exosome 
specific markers. The morphology and integrity of the 
isolated exosomes was first examined by SEM. The 
exosomes derived from the three cell lines, Molt-4, C81 
and HuT-102, had similar morphological characteristics 
Table 1 Primers sequence for qPCR
Primer Sequence Annealing 
temperature
VEGF F: AGGCCCACAGGGATTTTCTT 55
R: ATCAAACCTCACCAAGGCCA
Tax F: CGGATACCCAGTCTACGTGT 62
R: GAGCCGATAACGCGTCCATCG
CXCR4 F: CCTCCTGCTGACTATTCCCGA 55
R: GGAACACAACCACCCACAAGT
Nanog F: CAGAAGGCCTCAGCACCTAC 58
R: ATTGTTCCAGGTCTGGTTGC
MMP‑9 F: TTGACAGCGACAAGAAGTGG 55
R: GCCATTCACGTCGTCCTTAT
N‑Cadherin F: GGTGGAGGAGAAGAAGACCAG 58
R: GGCATCAGGCTCCACAGT
α‑SMA F: GACAGCTACGTGGGTGACGAA 58
R: TTTTCCATGTCGTCCCAGTTG
GAPDH F: TGGTGCTCAGTGTAGCCCAG 58
R: GGACCTGACCTGCCGTCTAG
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having a round shape and ranging in size from 50 to 
100  nm (Fig.  1a). The identity of the purified exosomes 
was confirmed by immuno-blotting for specific exosome 
markers. TSG-101, CD9 and CD63 were expressed in the 
exosomes isolated from Molt-4, C81 and HuT-102 cells 
where CD63 appeared as a smeared pattern between 
30–60 kDa (Fig. 1b).
The cargo of leukemia-derived exosomes included 
Tax which was detected in the exosomes isolated from 
HTLV-I positive cells and not in those isolated from 
negative cells, at the RNA and protein levels. Tax expres-
sion levels were comparable to that of the cells from 
which the exosomes were derived (Fig. 2a, b). We further 
demonstrated the presence of Tax mRNA in p-ATL cells 
and their derived exosomes (Fig.  2c). We investigated 
the expression of two miRNAs, miR-21 and miR-155, in 
HuT-102 cells and their derived exosomes, since both 
miRNAs were reported to be induced in HTLV-I posi-
tive cells [41, 42]. Interestingly, we detected miR-21 and 
miR-155 expression not only in HuT-102 cells but also 
in their derived exosomes (Fig.  2d). Both miRNAs were 
barely detectable in Molt-4 cells and exosomes while they 
were detected in C81 cells and exosomes at levels lower 
than those in HuT-102 cells and their derived exosomes 
Fig. 1 Characterization of exosomes derived from leukemic cells. a Scanning electron micrograph of exosomes isolated from Molt‑4, C81 and 
HuT‑102 cells, scale bar 1 µm. b A representative western blot showing the protein expression of TSG‑101, CD9, CD63 and GAPDH in the lysates of 
exosomes (15 µg) isolated from leukemic cells
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(Additional file  1: Fig. S1). The protein levels of VEGF, 
a pro-angiogenic molecule, are found either free in the 
supernatants of cultured cells or associated with their 
derived exosomes. We detected VEGF secretion levels 
in HuT-102-derived exosomes at concentrations com-
parable to those in HuT-102 cell culture supernatants 
(Fig. 2e).
Activation of NF‑κB pathway in MSCs by ATL‑derived 
exosomes
To explore whether Tax can be delivered from HuT-
102 cells to normal recipient cells via exosomes, we co-
cultured HuT-102-derived exosomes with MSCs. MSCs 
were chosen as recipient cells since they are the residents 
of the bone marrow niche and the microenvironment of 
Fig. 2 Detection of Tax, miR21, miR155 and VEGF in ATL‑derived exosomes. a Histogram representing the reciprocal value of Cq at which Tax 
expression was detected in leukemic cells and their derived exosomes (***p ≤ 0.005). b A representative western blot showing Tax protein expres‑
sion in leukemic cell lysates (100 µg) and their derived exosomes (15 µg). GAPDH was used as an internal loading control for the cell lysates. c 
Histogram representing the reciprocal value of Cq at which Tax expression was detected in p‑ATL cells and their exosomes, as compared to HuT‑102 
cells. d Histogram representing the normalized expression of miR‑155 and miR‑21 in HuT‑102 cells and their derived‑exosomes, as detected by qPCR 
(*p ≤ 0.05; **p ≤ 0.01). e Histogram representing VEGF protein levels detected in the supernatants or exosomes isolated from HuT‑102 cells by ELISA
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metastatic sites where they potentially interact with leu-
kemic cells and/or their derived exosomes. Interestingly, 
significant levels of Tax mRNA were detected in MSCs 
recipient of HuT-102-derived exosomes, as compared 
to control MSCs. To provide evidence that Tax is deliv-
ered through exosomes and not through viral particles, 
we isolated exosomes from C81 cells, an HTLV-I trans-
formed cell line but defective in virion production. Tax 
Fig. 3 Activation of NF‑κB pathway in MSCs by ATL‑derived exosomes. a Histogram representing the normalized fold expression of Tax in MSCs 
following co‑culture with C81‑ or HuT‑102‑derived exosomes, as detected by qPCR (*p < 0.05; ***p ≤ 0.005). b Representative western blot of Tax 
expression in MSCS recipient of C81 or HuT‑102 exosomes, as compared to MSCs control cells. c Representative western blots of phospho‑p65 
expression in MSCs control or co‑cultured with Molt‑4, C81 and HuT‑102‑derived exosomes. Actin was used as an internal loading control. d Densi‑
tometry analysis of phospho‑p65 protein expression in recipient MSCs from two independent western blot experiments. e, f Fluorescence images 
of phospho‑p65 expression in MSCs control or co‑cultured with HuT‑102 exosomes, respectively. g Histogram representing the quantification of the 
mean fluorescence intensity of phospho‑p65 expression in MSCs, control or co‑cultured with HuT‑102 exosomes, in six different fields acquired by 
LSM710 laser scanning microscope using a 63× objective lens, scale bar 10 µm (*p < 0.05)
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mRNA expression was detected at significant levels in 
MSCs following co-culture with C81 exosomes, yet at 
lower levels than those detected in MSCs co-cultured 
with HuT-102 exosomes (Fig.  3a). At the protein level, 
Tax expression was found at low levels in MSCs recipient 
of HuT-102-derived exosomes (Fig. 3b).
We then examined whether ATL-derived exosomes 
can activate NF-κB pathway, the main target of Tax onco-
protein [43], in MSCs. Interestingly, the expression of 
phospho-p65, the phosphorylated form of NF-κB subunit 
p65, was induced in MSCs recipient of C81 and HuT-102 
exosomes by two and five fold, respectively, as compared 
to MSCs control or recipient of Molt-4 exosomes (Fig. 3c, 
d). This finding was further confirmed by immunofluo-
rescence where a significant increase in phospho-p65 
staining was observed when MSCs received HuT-102 
exosomes (Fig.  3e–g). In addition, NF-κB p50 and p65 
subunits were both induced in MSCs following co-cul-
ture with HuT-102-derived exosomes (Additional file  2: 
Fig. S2).
ATL‑derived exosomes induce MSCs proliferation 
and expression of NF‑κB target genes
One of the main targets of Tax is the activation of NF-κB 
pathway which induces cell proliferation and transforma-
tion [43–45]. In fact, targeting HTLV-I transformed cells 
by the combinational treatment of As and IFN resulted 
in Tax down-regulation and cell death induction [46, 47]. 
To prove that Tax-containing exosomes can modulate 
MSCs proliferative properties, we first demonstrated that 
exosomes are indeed up taken by MSCs where PKH26-
labeled exosomes from HuT-102 cells were success-
fully internalized following co-culture for 24 h (Fig. 4a). 
Upon entry of HuT-102-derived exosomes, which con-
tained higher levels of Tax mRNA and protein than C81 
exosomes (Fig.  2a, b), MSCs proliferation was greatly 
affected where their confluency was clearly higher and 
cell proliferation was induced by 60 % (Fig. 4b), as com-
pared to cells cultured alone. This surge in proliferation 
was proven to be Tax-dependent since the combinational 
treatment of As and IFN reverted back the proliferative 
ability of MSCs recipient of HuT-102-derived exosomes 
to reach that of MSCs control (Fig. 4c).
The activation of NF-κB pathway involves an array of 
target genes involved in cell proliferation, migration and 
angiogenesis. Therefore, we checked the expression of 
stemness markers and migration genes in MSCs modu-
lated by HuT-102 exosomes. At the transcriptional level, 
the expression of stemness markers alpha-smooth muscle 
actin (α-SMA) and N-cadherin was significantly decreased 
Fig. 4 Induction of MSCs proliferation by ATL‑derived exosomes. a 
Fluorescence images of MSCs following the uptake of PKH26‑labeled 
HuT‑102 exosomes (red color), scale bar 10 µm. Hoechst is used as a 
nuclear stain (blue color). b Bright field images of MSCs cultured alone 
or with 30 µg of HuT‑102‑derived exosomes for 72 h, scale bar 40 µm. 
Histogram representing the proliferation of MSCs after co‑culture with 
leukemia‑derived exosomes for 72 h (*p < 0.05). c Histogram repre‑
senting the proliferation of MSCs after co‑culture with HuT‑102‑de‑
rived exosomes for 72 h, with or without As/IFN treatment (*p < 0.05)
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in MSCs modulated by HuT-102-derived exosomes 
(Fig. 5a). Although Nanog expression levels did not reach 
statistical significance, a decrease in mRNA levels was 
observed in MSCs co-cultured with exosomes harbor-
ing Tax. Furthermore, mRNA expression of CXCR4 and 
MMP-9 migration markers was significantly up-regulated 
in MSCs recipient of HuT-102 exosomes (Fig.  5b). The 
protein expression of VEGF, one of NF-κB target genes 
[48], was also increased in MSCs modulated by C81- and 
HuT-102-derived exosomes, as compared to MSCs control 
or MSCs modulated by Molt-4 exosomes (Fig. 5c, d).
Discussion
Although HTLV-I transmission modes are well estab-
lished, we hypothesize a novel infection method via 
exosomes whereby the main oncoprotein Tax can be 
delivered to normal recipient cells and subsequently acti-
vates NF-κB pathway involved in cellular transformation. 
The suggested infection via ATL-derived exosomes is 
even more effective since they can target a variety of cell 
lines in contrast to HTLV-I infection which specifically 
targets T cells [1, 2]. Since the role of exosomes in HTLV-
I modulation of MSCs, residents of the bone marrow and 
metastatic niches, is not yet explored, we investigated 
whether exosomes derived from HTLV-I-infected cells 
can alter MSCs properties in favor of leukemia.
After the physical and molecular characterization of 
collected exosomes, we detected the expression of Tax in 
the exosomes of C81 and HuT-102 cells but not in those 
from Molt-4 cells, at the transcriptional and transla-
tional levels. Interestingly, we detected Tax mRNA in the 
exosomes isolated from p-ATL cells which underscores 
the in vivo relevance of such finding. Tax protein expres-
sion was previously reported in HTLV-I positive cell 
lines [36]. Our study is the first to detect the expression 
of two miRNAs, miR-21 and miR-155 in HTLV-I-derived 
Fig. 5 Activation of NF‑κB target genes in MSCs by ATL‑derived exosomes. a, b Histograms representing the normalized fold expression of α‑SMA, 
N‑cadherin, CXCR4 and MMP‑9 in MSCs control or co‑cultured with HuT‑102‑derived exosomes, as detected by qPCR (*p < 0.05; ***p < 0.005). c 
Representative western blots of VEGF expression in MSCs control or co‑cultured with Molt‑4, C81 and HuT‑102‑derived exosomes. Actin was used 
as an internal loading control. d Histogram representing the densitometry analysis of VEGF protein expression from two independent western blot 
experiments
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exosomes. In fact, both microRNAs are up-regulated 
in HTLV-I/Tax positive cells. They enhance leukemic 
cell proliferation by suppressing the expression of pro-
teins regulating p53-dependent cell death and proteins 
involved in inhibition of cell proliferation. In particular, 
miR-155 has an additive value to the HTLV-I exosomal 
cargo due to its close association with Tax where miR-
155 was found to be induced by Tax through NF-κB 
activation of its promoter [41, 42]. We also revealed 
the existence of a pro-angiogenic molecule, VEGF, in 
the exosomes released by HuT-102 cells. ELISA results 
showed high detection levels of VEGF protein in HuT-
102-derived exosomes as compared to HuT-102 super-
natants. Only two studies checked for the presence of 
VEGF in cancer-exosomes but the obtained data was 
based on solid and not hematological cancers. The first 
one reported the transcripts of VEGF A and C in the 
exosomes of a rat pancreatic adenocarcinoma cell line 
[49]. Another group showed that VEGF, IL-6 and MMP-2 
proteins were present in the culture supernatants of 
human melanoma cells with no direct evidence of VEGF 
detection in their derived exosomes [50].
We then investigated whether ATL-derived exosomes 
can be transferred to normal recipient cells and 
consequently modulate their properties. Our ration-
ale for the choice of MSCs as target cells is that they 
are in  vivo the resident cells of the bone marrow niche 
and the metastatic niches [51], where MSCs potentially 
interact with leukemic cells. Following direct co-culture 
experiments, HuT-102-derived exosomes were able to 
transfer Tax mRNA to recipient MSCs. Although the 
transfer of Tax to target cells could be potentially medi-
ated by viral particles, we showed that exosomes from 
C81 cells, an HTLV-I transformed cell line but defective 
in virion production, harbored Tax mRNA and protein, 
and conveyed Tax to MSCs. The delivery of Tax to target 
cells via exosomes was studied by another group, how-
ever the recipient cells were either HTLV-I negative cells 
(Jurkat), cytotoxic T cells (CTLL-2) or peripheral blood 
mononuclear cells (PBMCs) [36, 52], all of which are a 
direct source of T cells (60–85 % in PBMCs [52]), the nat-
ural targets for HTLV-I transformation.
Since NF-κB is one of the targeted pathways by Tax [4, 
5], we examined if Tax-containing exosomes can induce 
NF-κB activation in MSCs, our target cells. In fact, we 
showed that phospho-p65 subunit is up-regulated in 
MSCs recipient of ATL-derived exosomes. Studies have 
shown that the phosphorylation of NF-κB subunit p65, 
Fig. 6 Schematic illustrating the reciprocal interaction between MSCs and ATL cells mediated by ATL‑derived exosomes. Exosomes are secreted by 
ATL cells carrying leukemia‑associated genes including Tax, VEGF and miRNAs (miR‑21 and ‑155), in addition to exosome specific genes (TSG‑101, 
CD9 and CD63). Upon delivery of ATL‑derived exosomes to MSCs, NF‑κB pathway is activated leading to IκB‑α phosphorylation and subsequent 
degradation. The RelA/p50 dimer is now free to translocate into the nucleus and activate cellular events such as proliferation and gene expression 
of migration (MMP‑9 and CXCR4) and angiogenic (VEGF) markers. This in turn supports ATL cells, either by paracrine interaction (soluble factors and 
exosomes) or by direct cell–cell contact, by creating the right microenvironment that will help ATL cells to proliferate, invade and disseminate to 
distant sites
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specifically at Serine 536, enhances p65 transcriptional 
activity [53]. We then investigated the downstream effects 
of NF-κB activation by Tax-exosomes by assessing MSCs 
proliferation and gene expression profile. We first showed 
that HuT-102-derived exosomes are certainly up taken 
and internalized by MSCs, as shown by the detection of 
PKH26-labeled exosomes inside MSCs. We then demon-
strated that the delivery of Hut-102-derived exosomes, 
which contained high levels of Tax mRNA and protein, 
significantly induced MSCs’ proliferation by 60 % increase 
which was also evident in the enhanced confluency of the 
cells. This surge in proliferation was reduced with As/IFN 
combinational treatment further proving that the effect is 
Tax-dependent, even though the effect of other players, 
identified or not, in ATL-exosomes should not be over-
looked. Tax-containing exosomes were shown to support 
proliferation and survival of cytotoxic T cells and PBMCs 
[36]. In addition, the expression of stemness markers such 
as α-SMA and N-cadherin expression were significantly 
decreased in MSCs recipient of HuT-102 exosomes. On 
the other hand, the expression of angiogenic and migration 
markers such as VEGF, CXCR4 and MMP-9 was induced 
in MSCs following interaction with HuT-102-derived 
exosomes. This data suggests that ATL-derived exosomes 
modulate MSCs properties causing them to lose their 
stemness properties in favor of a migratory and angio-
genic phenotype that might support leukemia progression. 
Induction of VEGF and MMP expression is in accord-
ance with other studies performed on exosomes released 
by solid cancers. Prostate and breast cancer-derived 
exosomes induced the differentiation of MSCs into myofi-
broblast-like cells secreting VEGF, SDF-1, TGF-β1 and 
MMPs, contributing to disease progression [38, 40]. As for 
the role of exosomes from hematological malignancies in 
modulating surrounding stromal cells, most of the studies 
focused on AML- and CML-derived exosomes promoting 
angiogenic ability in endothelial cells [27–30, 39].
Conclusions
This study demonstrates that Tax, along with other leu-
kemia-related players, is delivered to MSCs via ATL-
derived exosomes. This results in the activation of NF-κB 
pathway and its target genes involved in proliferation, 
migration and angiogenesis. These modulated MSCs pre-
sumably support ATL cells, either by paracrine interac-
tion (soluble factors and exosomes) or by direct cell–cell 
contact, by creating a more conducive milieu for leuke-
mia (Fig. 6). These findings highlight the contribution of 
leukemia-derived exosomes in cellular transformation 
and their potential value as biomarkers and targets in 
therapeutic strategies.
Abbreviations
miRNA: microRNA; MSCs: mesenchymal stem cells; ATL: adult T‑cell leukemia/
lymphoma; VEGF: vascular endothelial growth factor; NF‑κB: nuclear factor‑
kappa B; HTLV‑I: human T‑cell lymphotropic virus type I; CML: chronic myeloid 
leukemia; AML: acute myeloid leukemia; CLL: chronic lymphocytic leukemia; 
PBS: phosphate buffered saline; FBS: fetal bovine serum; NGS: normal goat 
serum; mRNA: messenger RNA; qPCR: quantitative polymerase chain reaction; 
Cq: quantitative cycle; p‑ATL: patient‑derived ATL cells; SEM: scanning electron 
microscope; IFN: recombinant human interferon‑alpha; As: arsenic trioxide; 
CXCR4: C‑X‑C chemokine receptor type 4; MMP‑9: matrix metalloproteinase 
9; α‑SMA: alpha‑smooth muscle actin; TGF‑β1: transforming growth factor β1; 
PBMCs: peripheral blood mononuclear cells.
Authors’ contributions
JES performed the experiments, analyzed data and wrote the manuscript. FN 
performed the miRNA screening assays. NT provided and maintained patients‑
derived cells. MES conceived and designed the study, analyzed data and wrote 
the manuscript. All authors read and approved the final manuscript. 
Author details
1 Department of Anatomy, Cell Biology and Physiological Sciences, Faculty 
of Medicine, American University of Beirut, Beirut, Lebanon. 2 Department 
of Internal Medicine and Experimental Pathology, Faculty of Medicine, 
American University of Beirut, Beirut, Lebanon. 3 Department of Immunology 
and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, 
Lebanon. 
Acknowledgements
We acknowledge Dr. Hiba El‑Hajj (Faculty of Medicine, American University of 
Beirut, Beirut, Lebanon) for providing the p‑ATL cells. We thank Dr. Rihab Nasr 
(Faculty of Medicine, American University of Beirut, Beirut, Lebanon) for her intel‑
lectual input and expertise in the conduction of miRNA experiments.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The data supporting this work’s conclusions is included within the manuscript.
Ethics approval and consent to participate
According the American University of Beirut Institutional Review Board (IRB) 
guidelines, no IRB approval is needed to perform research on material from 
deceased patients.
Funding
This work was supported by grants from Lebanese National Council for 
Scientific Research (LNCSR) and Grants from Medical Practice Plan (MPP) and 
University Research Board (URB) at the American University of Beirut.
Received: 29 July 2016   Accepted: 4 October 2016
Additional files
Additional file 1: Fig. S1. Detection of miR155 and miR21 in leuke‑
mic cells and their derived exosomes. a, b Histograms representing the 
normalized expression of miR‑155 and miR‑21, respectively, in Molt‑4, C81 
and HuT‑102 cells and their derived‑exosomes, as detected by qPCR.
Additional file 2: Fig. S2. Activation of NF‑κB pathway in MSCs by 
Hut‑102‑derived exosomes. a Representative western blot of p50 and 
p65 expression in MSCs control or co‑cultured with HuT‑102‑derived 
exosomes. GAPDH was used as an internal loading control. b Histogram 
showing densitometry analysis of p50 and p65 protein expression in MSCs 
control or recipient of HuT‑102 exosomes, after normalization to GAPDH.
Page 12 of 13El‑Saghir et al. Retrovirology  (2016) 13:73 
References
 1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T‑cell leuke‑
mia: clinical and hematologic features of 16 cases. Blood. 1977;50:481–92.
 2. Hinuma Y, Komoda H, Chosa T, Kondo T, Kohakura M, Takenaka T, Kikuchi 
M, Ichimaru M, Yunoki K, Sato I, Matsuo R, Takiuchi Y, Uchino H, Hanaoka 
M. Antibodies to adult T‑cell leukemia‑virus‑associated antigen (ATLA) in 
sera from patients with ATL and controls in Japan: a nation‑wide sero‑
epidemiologic study. Int J Cancer. 1982;29:631–5.
 3. Wano Y, Feinberg M, Hosking JB, Bogerd H, Greene WC. Stable expression 
of the tax gene of type I human T‑cell leukemia virus in human T cells 
activates specific cellular genes involved in growth. Proc Natl Acad Sci 
USA. 1988;85:9733–7.
 4. Azran I, Schavinsky‑Khrapunsky Y, Aboud M. Role of Tax protein in human 
T‑cell leukemia virus type‑I leukemogenicity. Retrovirology. 2004;1:20.
 5. Grassmann R, Aboud M, Jeang KT. Molecular mechanisms of cellular 
transformation by HTLV‑1 Tax. Oncogene. 2005;24:5976–85.
 6. Cheng H, Ren T, Sun SC. New insight into the oncogenic mechanism of 
the retroviral oncoprotein Tax. Protein Cell. 2012;3:581–9.
 7. Qu Z, Xiao G. Human T‑cell lymphotropic virus: a model of NF‑kappaB‑
associated tumorigenesis. Viruses. 2011;3:714–49.
 8. Kfoury Y, Nasr R, Journo C, Mahieux R, Pique C, Bazarbachi A. The multifac‑
eted oncoprotein Tax: subcellular localization, posttranslational modifica‑
tions, and NF‑kappaB activation. Adv Cancer Res. 2012;113:85–120.
 9. Macaire H, Riquet A, Moncollin V, Biemont‑Trescol MC, Duc Dodon M, 
Hermine O, Debaud AL, Mahieux R, Mesnard JM, Pierre M, Gazzolo L, 
Bonnefoy N, Valentin H. Tax protein‑induced expression of antiapoptotic 
Bfl‑1 protein contributes to survival of human T‑cell leukemia virus type 1 
(HTLV‑1)‑infected T‑cells. J Biol Chem. 2012;287:21357–70.
 10. Wang W, Zhou J, Shi J, Zhang Y, Liu S, Liu Y, Zheng D. Human T‑cell leuke‑
mia virus type 1 Tax‑deregulated autophagy pathway and c‑FLIP expres‑
sion contribute to resistance against death receptor‑mediated apoptosis. 
J Virol. 2014;88:2786–98.
 11. Trams EG, Lauter CJ, Salem N Jr, Heine U. Exfoliation of membrane 
ecto‑enzymes in the form of micro‑vesicles. Biochim Biophys Acta. 
1981;645:63–70.
 12. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation 
during reticulocyte maturation. Association of plasma membrane activi‑
ties with released vesicles (exosomes). J Biol Chem. 1987;262:9412–20.
 13. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ. Exosome: 
from internal vesicle of the multivesicular body to intercellular signaling 
device. J Cell Sci. 2000;113(Pt 19):3365–74.
 14. Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular 
interactions of exosomes and other extracellular vesicles. Annu Rev Cell 
Dev Biol. 2014;30:255–89.
 15. Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current 
knowledge of their composition, biological functions, and diagnostic and 
therapeutic potentials. Biochim Biophys Acta. 2012;1820:940–8.
 16. Benito‑Martin A, Di Giannatale A, Ceder S, Peinado H. The new deal: a 
potential role for secreted vesicles in innate immunity and tumor pro‑
gression. Front Immunol. 2015;6:66.
 17. Saleem SN, Abdel‑Mageed AB. Tumor‑derived exosomes in oncogenic 
reprogramming and cancer progression. Cell Mol Life Sci. 2015;72:1–10.
 18. Malek AV, Bershtein LM, Filatov MV, Beliaev AM. Exosomal intercellular 
communication system and its role in the process of metastatic dissemi‑
nation. Vopr Onkol. 2014;60:429–36.
 19. Katsuda T, Kosaka N, Ochiya T. The roles of extracellular vesicles in cancer 
biology: toward the development of novel cancer biomarkers. Proteom‑
ics. 2014;14:412–25.
 20. Reiners KS, Topolar D, Henke A, Simhadri VR, Kessler J, Sauer M, Bessler 
M, Hansen HP, Tawadros S, Herling M, Kronke M, Hallek M, Pogge von 
Strandmann E. Soluble ligands for NK cell receptors promote evasion 
of chronic lymphocytic leukemia cells from NK cell anti‑tumor activity. 
Blood. 2013;121:3658–65.
 21. Hedlund M, Nagaeva O, Kargl D, Baranov V, Mincheva‑Nilsson L. Thermal‑ 
and oxidative stress causes enhanced release of NKG2D ligand‑bearing 
immunosuppressive exosomes in leukemia/lymphoma T and B cells. 
PLoS One. 2011;6:e16899.
 22. Whiteside TL. Immune modulation of T‑cell and NK (natural killer) cell 
activities by TEXs (tumour‑derived exosomes). Biochem Soc Trans. 
2013;41:245–51.
 23. Hong CS, Muller L, Boyiadzis M, Whiteside TL. Isolation and characteriza‑
tion of CD34+ blast‑derived exosomes in acute myeloid leukemia. PLoS 
One. 2014;9:e103310.
 24. Shen C, Hao S, Zhao C, Zhu J, Wang C. Antileukaemia immunity: effect 
of exosomes against NB4 acute promyelocytic leukaemia cells. J Int Med 
Res. 2011;39:740–7.
 25. Yao Y, Wang C, Wei W, Shen C, Deng X, Chen L, Ma L, Hao S. Dendritic 
cells pulsed with leukemia cell‑derived exosomes more efficiently induce 
antileukemic immunities. PLoS One. 2014;9:e91463.
 26. Gu X, Erb U, Buchler MW, Zoller M. Improved vaccine efficacy of tumor 
exosome compared to tumor lysate loaded dendritic cells in mice. Int J 
Cancer. 2015;136:E74–84.
 27. Taverna S, Amodeo V, Saieva L, Russo A, Giallombardo M, De Leo G, Ales‑
sandro R. Exosomal shuttling of miR‑126 in endothelial cells modulates 
adhesive and migratory abilities of chronic myelogenous leukemia cells. 
Mol Cancer 2014;13:169–83.
 28. Mineo M, Garfield SH, Taverna S, Flugy A, De Leo G, Alessandro R, Kohn 
EC. Exosomes released by K562 chronic myeloid leukemia cells promote 
angiogenesis in a Src‑dependent fashion. Angiogenesis. 2012;15:33–45.
 29. Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH. Leukemia cell to 
endothelial cell communication via exosomal miRNAs. Oncogene. 
2013;32:2747–55.
 30. Tadokoro H, Umezu T, Ohyashiki K, Hirano T, Ohyashiki JH. Exosomes 
derived from hypoxic leukemia cells enhance tube formation in endothe‑
lial cells. J Biol Chem. 2013;288:34343–51.
 31. Hu G, Drescher KM, Chen XM. Exosomal miRNAs: biological properties 
and therapeutic potential. Front Genet. 2012;3:56.
 32. Yeh YY, Ozer HG, Lehman AM, Maddocks K, Yu L, Johnson AJ, Byrd 
JC. Characterization of CLL exosomes reveals a distinct microRNA 
signature and enhanced secretion by activation of BCR signaling. Blood. 
2015;125:3297–305.
 33. Feng DQ, Huang B, Li J, Liu J, Chen XM, Xu YM, Chen X, Zhang HB, Hu LH, 
Wang XZ. Selective miRNA expression profile in chronic myeloid leuke‑
mia K562 cell‑derived exosomes. Asian Pac J Cancer Prev. 2013;14:7501–8.
 34. Huan J, Hornick NI, Shurtleff MJ, Skinner AM, Goloviznina NA, Roberts CT 
Jr, Kurre P. RNA trafficking by acute myelogenous leukemia exosomes. 
Cancer Res. 2013;73:918–29.
 35. Corrado C, Raimondo S, Saieva L, Flugy AM, De Leo G, Alessandro R. 
Exosome‑mediated crosstalk between chronic myelogenous leukemia 
cells and human bone marrow stromal cells triggers an interleukin 
8‑dependent survival of leukemia cells. Cancer Lett. 2014;348:71–6.
 36. Jaworski E, Narayanan A, Van Duyne R, Shabbeer‑Meyering S, Iordanskiy 
S, Saifuddin M, Das R, Afonso PV, Sampey GC, Chung M, Popratiloff A, 
Shrestha B, Sehgal M, Jain P, Vertes A, Mahieux R, Kashanchi F. Human 
T‑lymphotropic virus type 1‑infected cells secrete exosomes that contain 
Tax protein. J Biol Chem. 2014;289:22284–305.
 37. El Hajj H, Khalil B, Ghandour B, Nasr R, Shahine S, Ghantous A, Abdel‑
Samad R, Sinjab A, Hasegawa H, Jabbour M, Hall WW, Zaatari G, Dbaibo 
G, Pisano C, Bazarbachi A, Darwiche N. Preclinical efficacy of the synthetic 
retinoid ST1926 for treating adult T‑cell leukemia/lymphoma. Blood. 
2014;124:2072–80.
 38. Cho JA, Park H, Lim EH, Lee KW. Exosomes from breast cancer cells can 
convert adipose tissue‑derived mesenchymal stem cells into myofibro‑
blast‑like cells. Int J Oncol. 2012;40:130–8.
 39. Taverna S, Flugy A, Saieva L, Kohn EC, Santoro A, Meraviglia S, De Leo 
G, Alessandro R. Role of exosomes released by chronic myelogenous 
leukemia cells in angiogenesis. Int J Cancer. 2012;130:2033–43.
 40. Chowdhury R, Webber JP, Gurney M, Mason MD, Tabi Z, Clayton A. 
Cancer exosomes trigger mesenchymal stem cell differentiation 
into pro‑angiogenic and pro‑invasive myofibroblasts. Oncotarget. 
2015;6:715–31.
 41. Tomita M. Important roles of cellular MicroRNA miR‑155 in leukemo‑
genesis by human T‑cell leukemia virus type 1 infection. ISRN Microbiol. 
2012;2012:978607. doi:10.5402/2012/978607.
 42. Pichler K, Schneider G, Grassmann R. MicroRNA miR‑146a and further 
oncogenesis‑related cellular microRNAs are dysregulated in HTLV‑1‑trans‑
formed T lymphocytes. Retrovirology 2008;5:100–11.
 43. Yoshida M. Mechanism of transcriptional activation of viral and cel‑
lular genes by oncogenic protein of HTLV‑1. Leukemia. 1994;8(Suppl 
1):S51–3.
Page 13 of 13El‑Saghir et al. Retrovirology  (2016) 13:73 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 44. Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M, Hatanaka M. Onco‑
genic transformation by the tax gene of human T‑cell leukemia virus type 
I in vitro. Proc Natl Acad Sci USA. 1990;87:1071–5.
 45. Marriott SJ, Lindholm PF, Reid RL, Brady JN. Soluble HTLV‑I Tax1 protein 
stimulates proliferation of human peripheral blood lymphocytes. New 
Biol. 1991;3:678–86.
 46. Bazarbachi A, El‑Sabban ME, Nasr R, Quignon F, Awaraji C, Kersual J, 
Dianoux L, Zermati Y, Haidar JH, Hermine O, de The H. Arsenic trioxide 
and interferon‑alpha synergize to induce cell cycle arrest and apopto‑
sis in human T‑cell lymphotropic virus type I‑transformed cells. Blood. 
1999;93:278–83.
 47. El‑Sabban ME, Nasr R, Dbaibo G, Hermine O, Abboushi N, Quignon F, 
Ameisen JC, Bex F, de The H, Bazarbachi A. Arsenic‑interferon‑alpha‑trig‑
gered apoptosis in HTLV‑I transformed cells is associated with tax down‑
regulation and reversal of NF‑kappa B activation. Blood. 2000;96:2849–55.
 48. Zhao T, Yasunaga J, Satou Y, Nakao M, Takahashi M, Fujii M, Matsuoka M. 
Human T‑cell leukemia virus type 1 bZIP factor selectively suppresses the 
classical pathway of NF‑kappaB. Blood. 2009;113:2755–64.
 49. Nazarenko I, Rana S, Baumann A, McAlear J, Hellwig A, Trendelenburg 
M, Lochnit G, Preissner KT, Zoller M. Cell surface tetraspanin Tspan8 
contributes to molecular pathways of exosome‑induced endothelial cell 
activation. Cancer Res. 2010;70:1668–78.
 50. Ekstrom EJ, Bergenfelz C, von Bulow V, Serifler F, Carlemalm E, Jonsson G, 
Andersson T, Leandersson K. WNT5A induces release of exosomes con‑
taining pro‑angiogenic and immunosuppressive factors from malignant 
melanoma cells. Mol Cancer 2014;13:88–102.
 51. Ilmer M, Vykoukal J, Recio Boiles A, Coleman M, Alt E. Two sides of the 
same coin: stem cells in cancer and regenerative medicine. FASEB J. 
2014;28:2748–61.
 52. Reichert T, DeBruyere M, Deneys V, Totterman T, Lydyard P, Yuksel F, 
Chapel H, Jewell D, Van Hove L, Linden J. Lymphocyte subset refer‑
ence ranges in adult Caucasians. Clin Immunol Immunopathol. 
1991;60:190–208.
 53. Bakkar N, Guttridge DC. NF‑kappaB signaling: a tale of two pathways in 
skeletal myogenesis. Physiol Rev. 2010;90:495–511.
